nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—SLCO2A1—Furosemide—coronary artery disease	0.132	0.211	CbGbCtD
Alprostadil—SLCO2B1—Pitavastatin—coronary artery disease	0.0833	0.134	CbGbCtD
Alprostadil—ABCC5—Atorvastatin—coronary artery disease	0.081	0.13	CbGbCtD
Alprostadil—SLCO2B1—Niacin—coronary artery disease	0.0723	0.116	CbGbCtD
Alprostadil—SLCO2B1—Rosuvastatin—coronary artery disease	0.0614	0.0987	CbGbCtD
Alprostadil—SLCO2B1—Pravastatin—coronary artery disease	0.0559	0.0898	CbGbCtD
Alprostadil—SLCO2B1—Atorvastatin—coronary artery disease	0.0509	0.0818	CbGbCtD
Alprostadil—ABCC4—Rosuvastatin—coronary artery disease	0.0469	0.0754	CbGbCtD
Alprostadil—ABCC4—Atorvastatin—coronary artery disease	0.0389	0.0625	CbGbCtD
Alprostadil—PTGIR—pulmonary artery—coronary artery disease	0.00934	0.237	CbGeAlD
Alprostadil—Ethanolamine Oleate—FABP5—coronary artery disease	0.0036	0.705	CrCbGaD
Alprostadil—PTGIR—artery—coronary artery disease	0.00346	0.088	CbGeAlD
Alprostadil—PTGIR—endothelium—coronary artery disease	0.00292	0.0744	CbGeAlD
Alprostadil—SLCO3A1—cardiac ventricle—coronary artery disease	0.00171	0.0436	CbGeAlD
Alprostadil—SLCO2A1—cardiac ventricle—coronary artery disease	0.0017	0.0432	CbGeAlD
Alprostadil—PTGER2—blood—coronary artery disease	0.00162	0.0413	CbGeAlD
Alprostadil—SLCO3A1—myocardium—coronary artery disease	0.00161	0.041	CbGeAlD
Alprostadil—SLCO2A1—myocardium—coronary artery disease	0.0016	0.0406	CbGeAlD
Alprostadil—ABCC5—cardiac ventricle—coronary artery disease	0.00155	0.0395	CbGeAlD
Alprostadil—ABCC5—myocardium—coronary artery disease	0.00146	0.0371	CbGeAlD
Alprostadil—Epoprostenol—P2RY12—coronary artery disease	0.00131	0.257	CrCbGaD
Alprostadil—PTGIR—heart—coronary artery disease	0.00127	0.0324	CbGeAlD
Alprostadil—PTGIR—cardiovascular system—coronary artery disease	0.0012	0.0306	CbGeAlD
Alprostadil—SLCO3A1—heart—coronary artery disease	0.00113	0.0286	CbGeAlD
Alprostadil—SLCO2A1—heart—coronary artery disease	0.00111	0.0283	CbGeAlD
Alprostadil—ABCC5—heart—coronary artery disease	0.00102	0.0259	CbGeAlD
Alprostadil—SLCO3A1—cardiac atrium—coronary artery disease	0.000962	0.0245	CbGeAlD
Alprostadil—SLCO2A1—cardiac atrium—coronary artery disease	0.000953	0.0242	CbGeAlD
Alprostadil—PTGIR—blood—coronary artery disease	0.000951	0.0242	CbGeAlD
Alprostadil—ABCC5—cardiac atrium—coronary artery disease	0.000872	0.0222	CbGeAlD
Alprostadil—SLCO3A1—blood—coronary artery disease	0.00084	0.0213	CbGeAlD
Alprostadil—SLCO2B1—heart—coronary artery disease	0.000798	0.0203	CbGeAlD
Alprostadil—ABCC4—heart—coronary artery disease	0.000706	0.018	CbGeAlD
Alprostadil—ABCC4—blood—coronary artery disease	0.000527	0.0134	CbGeAlD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—coronary artery disease	0.000201	0.0393	CrCbGaD
Alprostadil—Abdominal pain—Valsartan—coronary artery disease	8.04e-05	0.000403	CcSEcCtD
Alprostadil—Tachycardia—Losartan—coronary artery disease	8.03e-05	0.000402	CcSEcCtD
Alprostadil—Feeling abnormal—Pravastatin—coronary artery disease	8.02e-05	0.000402	CcSEcCtD
Alprostadil—Abdominal pain—Olmesartan—coronary artery disease	8e-05	0.000401	CcSEcCtD
Alprostadil—Body temperature increased—Olmesartan—coronary artery disease	8e-05	0.000401	CcSEcCtD
Alprostadil—Pruritus—Ezetimibe—coronary artery disease	7.99e-05	0.0004	CcSEcCtD
Alprostadil—Hypotension—Furosemide—coronary artery disease	7.96e-05	0.000399	CcSEcCtD
Alprostadil—Hyperhidrosis—Losartan—coronary artery disease	7.95e-05	0.000398	CcSEcCtD
Alprostadil—Dyspepsia—Captopril—coronary artery disease	7.95e-05	0.000398	CcSEcCtD
Alprostadil—Pain—Telmisartan—coronary artery disease	7.94e-05	0.000398	CcSEcCtD
Alprostadil—Diarrhoea—Clopidogrel—coronary artery disease	7.93e-05	0.000397	CcSEcCtD
Alprostadil—Asthenia—Eplerenone—coronary artery disease	7.93e-05	0.000397	CcSEcCtD
Alprostadil—Diarrhoea—Lovastatin—coronary artery disease	7.88e-05	0.000394	CcSEcCtD
Alprostadil—Nausea—Acetylsalicylic acid—coronary artery disease	7.84e-05	0.000393	CcSEcCtD
Alprostadil—Erythema—Lisinopril—coronary artery disease	7.84e-05	0.000392	CcSEcCtD
Alprostadil—Pruritus—Eplerenone—coronary artery disease	7.82e-05	0.000392	CcSEcCtD
Alprostadil—Abdominal pain—Niacin—coronary artery disease	7.82e-05	0.000391	CcSEcCtD
Alprostadil—Body temperature increased—Niacin—coronary artery disease	7.82e-05	0.000391	CcSEcCtD
Alprostadil—Dizziness—Fenofibrate—coronary artery disease	7.8e-05	0.00039	CcSEcCtD
Alprostadil—Feeling abnormal—Trandolapril—coronary artery disease	7.79e-05	0.00039	CcSEcCtD
Alprostadil—Feeling abnormal—Enalapril—coronary artery disease	7.76e-05	0.000389	CcSEcCtD
Alprostadil—Syncope—Ramipril—coronary artery disease	7.75e-05	0.000388	CcSEcCtD
Alprostadil—Asthenia—Simvastatin—coronary artery disease	7.73e-05	0.000387	CcSEcCtD
Alprostadil—Diarrhoea—Ezetimibe—coronary artery disease	7.73e-05	0.000387	CcSEcCtD
Alprostadil—Dyspepsia—Perindopril—coronary artery disease	7.72e-05	0.000387	CcSEcCtD
Alprostadil—Abdominal pain—Pravastatin—coronary artery disease	7.7e-05	0.000385	CcSEcCtD
Alprostadil—Body temperature increased—Pravastatin—coronary artery disease	7.7e-05	0.000385	CcSEcCtD
Alprostadil—Hypotension—Losartan—coronary artery disease	7.68e-05	0.000385	CcSEcCtD
Alprostadil—Dizziness—Clopidogrel—coronary artery disease	7.66e-05	0.000384	CcSEcCtD
Alprostadil—Feeling abnormal—Telmisartan—coronary artery disease	7.65e-05	0.000383	CcSEcCtD
Alprostadil—Pruritus—Simvastatin—coronary artery disease	7.62e-05	0.000382	CcSEcCtD
Alprostadil—Dizziness—Lovastatin—coronary artery disease	7.61e-05	0.000381	CcSEcCtD
Alprostadil—Nervousness—Lisinopril—coronary artery disease	7.61e-05	0.000381	CcSEcCtD
Alprostadil—Loss of consciousness—Ramipril—coronary artery disease	7.59e-05	0.00038	CcSEcCtD
Alprostadil—Back pain—Lisinopril—coronary artery disease	7.58e-05	0.00038	CcSEcCtD
Alprostadil—Syncope—Timolol—coronary artery disease	7.57e-05	0.000379	CcSEcCtD
Alprostadil—Diarrhoea—Eplerenone—coronary artery disease	7.56e-05	0.000379	CcSEcCtD
Alprostadil—Cough—Ramipril—coronary artery disease	7.54e-05	0.000378	CcSEcCtD
Alprostadil—Muscle spasms—Lisinopril—coronary artery disease	7.53e-05	0.000377	CcSEcCtD
Alprostadil—Pain—Perindopril—coronary artery disease	7.5e-05	0.000376	CcSEcCtD
Alprostadil—Convulsion—Ramipril—coronary artery disease	7.49e-05	0.000375	CcSEcCtD
Alprostadil—Abdominal pain—Trandolapril—coronary artery disease	7.47e-05	0.000374	CcSEcCtD
Alprostadil—Body temperature increased—Trandolapril—coronary artery disease	7.47e-05	0.000374	CcSEcCtD
Alprostadil—Dizziness—Ezetimibe—coronary artery disease	7.47e-05	0.000374	CcSEcCtD
Alprostadil—Abdominal pain—Enalapril—coronary artery disease	7.44e-05	0.000373	CcSEcCtD
Alprostadil—Body temperature increased—Enalapril—coronary artery disease	7.44e-05	0.000373	CcSEcCtD
Alprostadil—Feeling abnormal—Captopril—coronary artery disease	7.44e-05	0.000373	CcSEcCtD
Alprostadil—Rash—Fenofibrate—coronary artery disease	7.43e-05	0.000372	CcSEcCtD
Alprostadil—Dermatitis—Fenofibrate—coronary artery disease	7.43e-05	0.000372	CcSEcCtD
Alprostadil—Loss of consciousness—Timolol—coronary artery disease	7.42e-05	0.000372	CcSEcCtD
Alprostadil—Headache—Fenofibrate—coronary artery disease	7.39e-05	0.00037	CcSEcCtD
Alprostadil—Cough—Timolol—coronary artery disease	7.37e-05	0.000369	CcSEcCtD
Alprostadil—Diarrhoea—Simvastatin—coronary artery disease	7.37e-05	0.000369	CcSEcCtD
Alprostadil—Body temperature increased—Telmisartan—coronary artery disease	7.34e-05	0.000368	CcSEcCtD
Alprostadil—Abdominal pain—Telmisartan—coronary artery disease	7.34e-05	0.000368	CcSEcCtD
Alprostadil—Dizziness—Eplerenone—coronary artery disease	7.31e-05	0.000366	CcSEcCtD
Alprostadil—Rash—Clopidogrel—coronary artery disease	7.31e-05	0.000366	CcSEcCtD
Alprostadil—Dermatitis—Clopidogrel—coronary artery disease	7.3e-05	0.000366	CcSEcCtD
Alprostadil—Asthenia—Valsartan—coronary artery disease	7.3e-05	0.000365	CcSEcCtD
Alprostadil—Hypertension—Timolol—coronary artery disease	7.29e-05	0.000365	CcSEcCtD
Alprostadil—Pain—Furosemide—coronary artery disease	7.29e-05	0.000365	CcSEcCtD
Alprostadil—Discomfort—Ramipril—coronary artery disease	7.27e-05	0.000364	CcSEcCtD
Alprostadil—Asthenia—Olmesartan—coronary artery disease	7.26e-05	0.000364	CcSEcCtD
Alprostadil—Headache—Clopidogrel—coronary artery disease	7.26e-05	0.000364	CcSEcCtD
Alprostadil—Rash—Lovastatin—coronary artery disease	7.26e-05	0.000364	CcSEcCtD
Alprostadil—Dermatitis—Lovastatin—coronary artery disease	7.25e-05	0.000363	CcSEcCtD
Alprostadil—Anaemia—Lisinopril—coronary artery disease	7.24e-05	0.000363	CcSEcCtD
Alprostadil—Dyspepsia—Losartan—coronary artery disease	7.24e-05	0.000363	CcSEcCtD
Alprostadil—Feeling abnormal—Perindopril—coronary artery disease	7.23e-05	0.000362	CcSEcCtD
Alprostadil—Headache—Lovastatin—coronary artery disease	7.21e-05	0.000361	CcSEcCtD
Alprostadil—Pruritus—Valsartan—coronary artery disease	7.19e-05	0.00036	CcSEcCtD
Alprostadil—Dry mouth—Ramipril—coronary artery disease	7.19e-05	0.00036	CcSEcCtD
Alprostadil—Pruritus—Olmesartan—coronary artery disease	7.16e-05	0.000359	CcSEcCtD
Alprostadil—Abdominal pain—Captopril—coronary artery disease	7.14e-05	0.000358	CcSEcCtD
Alprostadil—Body temperature increased—Captopril—coronary artery disease	7.14e-05	0.000358	CcSEcCtD
Alprostadil—Dizziness—Simvastatin—coronary artery disease	7.12e-05	0.000357	CcSEcCtD
Alprostadil—Rash—Ezetimibe—coronary artery disease	7.12e-05	0.000357	CcSEcCtD
Alprostadil—Dermatitis—Ezetimibe—coronary artery disease	7.11e-05	0.000356	CcSEcCtD
Alprostadil—Discomfort—Timolol—coronary artery disease	7.11e-05	0.000356	CcSEcCtD
Alprostadil—Asthenia—Niacin—coronary artery disease	7.09e-05	0.000355	CcSEcCtD
Alprostadil—Headache—Ezetimibe—coronary artery disease	7.07e-05	0.000354	CcSEcCtD
Alprostadil—Oedema—Ramipril—coronary artery disease	7.05e-05	0.000353	CcSEcCtD
Alprostadil—Dry mouth—Timolol—coronary artery disease	7.03e-05	0.000352	CcSEcCtD
Alprostadil—Pain—Losartan—coronary artery disease	7.03e-05	0.000352	CcSEcCtD
Alprostadil—Syncope—Lisinopril—coronary artery disease	7.03e-05	0.000352	CcSEcCtD
Alprostadil—Feeling abnormal—Furosemide—coronary artery disease	7.02e-05	0.000352	CcSEcCtD
Alprostadil—Nausea—Fenofibrate—coronary artery disease	7e-05	0.000351	CcSEcCtD
Alprostadil—Pruritus—Niacin—coronary artery disease	7e-05	0.00035	CcSEcCtD
Alprostadil—Asthenia—Pravastatin—coronary artery disease	6.98e-05	0.00035	CcSEcCtD
Alprostadil—Rash—Eplerenone—coronary artery disease	6.97e-05	0.000349	CcSEcCtD
Alprostadil—Dermatitis—Eplerenone—coronary artery disease	6.96e-05	0.000349	CcSEcCtD
Alprostadil—Diarrhoea—Valsartan—coronary artery disease	6.96e-05	0.000348	CcSEcCtD
Alprostadil—Shock—Ramipril—coronary artery disease	6.94e-05	0.000347	CcSEcCtD
Alprostadil—Body temperature increased—Perindopril—coronary artery disease	6.93e-05	0.000347	CcSEcCtD
Alprostadil—Abdominal pain—Perindopril—coronary artery disease	6.93e-05	0.000347	CcSEcCtD
Alprostadil—Diarrhoea—Olmesartan—coronary artery disease	6.92e-05	0.000347	CcSEcCtD
Alprostadil—Headache—Eplerenone—coronary artery disease	6.92e-05	0.000347	CcSEcCtD
Alprostadil—Thrombocytopenia—Ramipril—coronary artery disease	6.9e-05	0.000346	CcSEcCtD
Alprostadil—Oedema—Timolol—coronary artery disease	6.89e-05	0.000345	CcSEcCtD
Alprostadil—Pruritus—Pravastatin—coronary artery disease	6.89e-05	0.000345	CcSEcCtD
Alprostadil—Loss of consciousness—Lisinopril—coronary artery disease	6.89e-05	0.000345	CcSEcCtD
Alprostadil—Nausea—Clopidogrel—coronary artery disease	6.88e-05	0.000345	CcSEcCtD
Alprostadil—Tachycardia—Ramipril—coronary artery disease	6.88e-05	0.000345	CcSEcCtD
Alprostadil—Skin disorder—Ramipril—coronary artery disease	6.85e-05	0.000343	CcSEcCtD
Alprostadil—Infection—Timolol—coronary artery disease	6.85e-05	0.000343	CcSEcCtD
Alprostadil—Cough—Lisinopril—coronary artery disease	6.84e-05	0.000342	CcSEcCtD
Alprostadil—Nausea—Lovastatin—coronary artery disease	6.84e-05	0.000342	CcSEcCtD
Alprostadil—Hyperhidrosis—Ramipril—coronary artery disease	6.82e-05	0.000341	CcSEcCtD
Alprostadil—Rash—Simvastatin—coronary artery disease	6.79e-05	0.00034	CcSEcCtD
Alprostadil—Dermatitis—Simvastatin—coronary artery disease	6.78e-05	0.00034	CcSEcCtD
Alprostadil—Asthenia—Trandolapril—coronary artery disease	6.78e-05	0.00034	CcSEcCtD
Alprostadil—Shock—Timolol—coronary artery disease	6.78e-05	0.00034	CcSEcCtD
Alprostadil—Feeling abnormal—Losartan—coronary artery disease	6.78e-05	0.000339	CcSEcCtD
Alprostadil—Diarrhoea—Niacin—coronary artery disease	6.76e-05	0.000339	CcSEcCtD
Alprostadil—Asthenia—Enalapril—coronary artery disease	6.76e-05	0.000338	CcSEcCtD
Alprostadil—Headache—Simvastatin—coronary artery disease	6.75e-05	0.000338	CcSEcCtD
Alprostadil—Body temperature increased—Furosemide—coronary artery disease	6.74e-05	0.000337	CcSEcCtD
Alprostadil—Abdominal pain—Furosemide—coronary artery disease	6.74e-05	0.000337	CcSEcCtD
Alprostadil—Dizziness—Valsartan—coronary artery disease	6.72e-05	0.000337	CcSEcCtD
Alprostadil—Nausea—Ezetimibe—coronary artery disease	6.71e-05	0.000336	CcSEcCtD
Alprostadil—Skin disorder—Timolol—coronary artery disease	6.7e-05	0.000335	CcSEcCtD
Alprostadil—Dizziness—Olmesartan—coronary artery disease	6.69e-05	0.000335	CcSEcCtD
Alprostadil—Pruritus—Trandolapril—coronary artery disease	6.69e-05	0.000335	CcSEcCtD
Alprostadil—Hyperhidrosis—Timolol—coronary artery disease	6.66e-05	0.000334	CcSEcCtD
Alprostadil—Asthenia—Telmisartan—coronary artery disease	6.66e-05	0.000334	CcSEcCtD
Alprostadil—Pruritus—Enalapril—coronary artery disease	6.66e-05	0.000334	CcSEcCtD
Alprostadil—Diarrhoea—Pravastatin—coronary artery disease	6.66e-05	0.000334	CcSEcCtD
Alprostadil—Discomfort—Lisinopril—coronary artery disease	6.59e-05	0.00033	CcSEcCtD
Alprostadil—Hypotension—Ramipril—coronary artery disease	6.59e-05	0.00033	CcSEcCtD
Alprostadil—Pruritus—Telmisartan—coronary artery disease	6.57e-05	0.000329	CcSEcCtD
Alprostadil—Nausea—Eplerenone—coronary artery disease	6.56e-05	0.000329	CcSEcCtD
Alprostadil—Dizziness—Niacin—coronary artery disease	6.54e-05	0.000327	CcSEcCtD
Alprostadil—Dry mouth—Lisinopril—coronary artery disease	6.52e-05	0.000327	CcSEcCtD
Alprostadil—Body temperature increased—Losartan—coronary artery disease	6.5e-05	0.000326	CcSEcCtD
Alprostadil—Abdominal pain—Losartan—coronary artery disease	6.5e-05	0.000326	CcSEcCtD
Alprostadil—Asthenia—Captopril—coronary artery disease	6.48e-05	0.000325	CcSEcCtD
Alprostadil—Diarrhoea—Trandolapril—coronary artery disease	6.47e-05	0.000324	CcSEcCtD
Alprostadil—Diarrhoea—Enalapril—coronary artery disease	6.44e-05	0.000323	CcSEcCtD
Alprostadil—Hypotension—Timolol—coronary artery disease	6.44e-05	0.000323	CcSEcCtD
Alprostadil—Dizziness—Pravastatin—coronary artery disease	6.44e-05	0.000322	CcSEcCtD
Alprostadil—Rash—Valsartan—coronary artery disease	6.41e-05	0.000321	CcSEcCtD
Alprostadil—Dermatitis—Valsartan—coronary artery disease	6.41e-05	0.000321	CcSEcCtD
Alprostadil—Nausea—Simvastatin—coronary artery disease	6.4e-05	0.00032	CcSEcCtD
Alprostadil—Oedema—Lisinopril—coronary artery disease	6.4e-05	0.00032	CcSEcCtD
Alprostadil—Pruritus—Captopril—coronary artery disease	6.39e-05	0.00032	CcSEcCtD
Alprostadil—Rash—Olmesartan—coronary artery disease	6.38e-05	0.00032	CcSEcCtD
Alprostadil—Dermatitis—Olmesartan—coronary artery disease	6.37e-05	0.000319	CcSEcCtD
Alprostadil—Headache—Valsartan—coronary artery disease	6.37e-05	0.000319	CcSEcCtD
Alprostadil—Diarrhoea—Telmisartan—coronary artery disease	6.35e-05	0.000318	CcSEcCtD
Alprostadil—Infection—Lisinopril—coronary artery disease	6.35e-05	0.000318	CcSEcCtD
Alprostadil—Headache—Olmesartan—coronary artery disease	6.34e-05	0.000318	CcSEcCtD
Alprostadil—Shock—Lisinopril—coronary artery disease	6.29e-05	0.000315	CcSEcCtD
Alprostadil—Asthenia—Perindopril—coronary artery disease	6.29e-05	0.000315	CcSEcCtD
Alprostadil—Thrombocytopenia—Lisinopril—coronary artery disease	6.26e-05	0.000314	CcSEcCtD
Alprostadil—Dizziness—Trandolapril—coronary artery disease	6.25e-05	0.000313	CcSEcCtD
Alprostadil—Tachycardia—Lisinopril—coronary artery disease	6.24e-05	0.000313	CcSEcCtD
Alprostadil—Rash—Niacin—coronary artery disease	6.23e-05	0.000312	CcSEcCtD
Alprostadil—Dermatitis—Niacin—coronary artery disease	6.23e-05	0.000312	CcSEcCtD
Alprostadil—Dizziness—Enalapril—coronary artery disease	6.23e-05	0.000312	CcSEcCtD
Alprostadil—Skin disorder—Lisinopril—coronary artery disease	6.21e-05	0.000311	CcSEcCtD
Alprostadil—Dyspepsia—Ramipril—coronary artery disease	6.21e-05	0.000311	CcSEcCtD
Alprostadil—Pruritus—Perindopril—coronary artery disease	6.2e-05	0.000311	CcSEcCtD
Alprostadil—Headache—Niacin—coronary artery disease	6.19e-05	0.00031	CcSEcCtD
Alprostadil—Hyperhidrosis—Lisinopril—coronary artery disease	6.18e-05	0.00031	CcSEcCtD
Alprostadil—Diarrhoea—Captopril—coronary artery disease	6.18e-05	0.000309	CcSEcCtD
Alprostadil—Dizziness—Telmisartan—coronary artery disease	6.14e-05	0.000308	CcSEcCtD
Alprostadil—Rash—Pravastatin—coronary artery disease	6.14e-05	0.000307	CcSEcCtD
Alprostadil—Dermatitis—Pravastatin—coronary artery disease	6.13e-05	0.000307	CcSEcCtD
Alprostadil—Asthenia—Furosemide—coronary artery disease	6.12e-05	0.000306	CcSEcCtD
Alprostadil—Headache—Pravastatin—coronary artery disease	6.1e-05	0.000305	CcSEcCtD
Alprostadil—Dyspepsia—Timolol—coronary artery disease	6.07e-05	0.000304	CcSEcCtD
Alprostadil—Nausea—Valsartan—coronary artery disease	6.04e-05	0.000303	CcSEcCtD
Alprostadil—Pruritus—Furosemide—coronary artery disease	6.03e-05	0.000302	CcSEcCtD
Alprostadil—Nausea—Olmesartan—coronary artery disease	6.01e-05	0.000301	CcSEcCtD
Alprostadil—Diarrhoea—Perindopril—coronary artery disease	6e-05	0.0003	CcSEcCtD
Alprostadil—Hypotension—Lisinopril—coronary artery disease	5.98e-05	0.000299	CcSEcCtD
Alprostadil—Dizziness—Captopril—coronary artery disease	5.97e-05	0.000299	CcSEcCtD
Alprostadil—Rash—Trandolapril—coronary artery disease	5.96e-05	0.000299	CcSEcCtD
Alprostadil—Dermatitis—Trandolapril—coronary artery disease	5.96e-05	0.000298	CcSEcCtD
Alprostadil—Rash—Enalapril—coronary artery disease	5.94e-05	0.000297	CcSEcCtD
Alprostadil—Dermatitis—Enalapril—coronary artery disease	5.93e-05	0.000297	CcSEcCtD
Alprostadil—Headache—Trandolapril—coronary artery disease	5.92e-05	0.000297	CcSEcCtD
Alprostadil—Asthenia—Losartan—coronary artery disease	5.9e-05	0.000296	CcSEcCtD
Alprostadil—Headache—Enalapril—coronary artery disease	5.9e-05	0.000295	CcSEcCtD
Alprostadil—Pain—Timolol—coronary artery disease	5.9e-05	0.000295	CcSEcCtD
Alprostadil—Nausea—Niacin—coronary artery disease	5.87e-05	0.000294	CcSEcCtD
Alprostadil—Rash—Telmisartan—coronary artery disease	5.86e-05	0.000293	CcSEcCtD
Alprostadil—Dermatitis—Telmisartan—coronary artery disease	5.85e-05	0.000293	CcSEcCtD
Alprostadil—Diarrhoea—Furosemide—coronary artery disease	5.83e-05	0.000292	CcSEcCtD
Alprostadil—Pruritus—Losartan—coronary artery disease	5.82e-05	0.000291	CcSEcCtD
Alprostadil—Headache—Telmisartan—coronary artery disease	5.82e-05	0.000291	CcSEcCtD
Alprostadil—Feeling abnormal—Ramipril—coronary artery disease	5.81e-05	0.000291	CcSEcCtD
Alprostadil—Dizziness—Perindopril—coronary artery disease	5.8e-05	0.00029	CcSEcCtD
Alprostadil—Nausea—Pravastatin—coronary artery disease	5.78e-05	0.00029	CcSEcCtD
Alprostadil—Rash—Captopril—coronary artery disease	5.69e-05	0.000285	CcSEcCtD
Alprostadil—Dermatitis—Captopril—coronary artery disease	5.69e-05	0.000285	CcSEcCtD
Alprostadil—Feeling abnormal—Timolol—coronary artery disease	5.68e-05	0.000285	CcSEcCtD
Alprostadil—Headache—Captopril—coronary artery disease	5.66e-05	0.000283	CcSEcCtD
Alprostadil—Dizziness—Furosemide—coronary artery disease	5.64e-05	0.000282	CcSEcCtD
Alprostadil—Dyspepsia—Lisinopril—coronary artery disease	5.63e-05	0.000282	CcSEcCtD
Alprostadil—Diarrhoea—Losartan—coronary artery disease	5.63e-05	0.000282	CcSEcCtD
Alprostadil—Nausea—Trandolapril—coronary artery disease	5.62e-05	0.000281	CcSEcCtD
Alprostadil—Nausea—Enalapril—coronary artery disease	5.59e-05	0.00028	CcSEcCtD
Alprostadil—Body temperature increased—Ramipril—coronary artery disease	5.57e-05	0.000279	CcSEcCtD
Alprostadil—Abdominal pain—Ramipril—coronary artery disease	5.57e-05	0.000279	CcSEcCtD
Alprostadil—Rash—Perindopril—coronary artery disease	5.53e-05	0.000277	CcSEcCtD
Alprostadil—Dermatitis—Perindopril—coronary artery disease	5.52e-05	0.000277	CcSEcCtD
Alprostadil—Nausea—Telmisartan—coronary artery disease	5.52e-05	0.000276	CcSEcCtD
Alprostadil—Headache—Perindopril—coronary artery disease	5.49e-05	0.000275	CcSEcCtD
Alprostadil—Pain—Lisinopril—coronary artery disease	5.47e-05	0.000274	CcSEcCtD
Alprostadil—Abdominal pain—Timolol—coronary artery disease	5.45e-05	0.000273	CcSEcCtD
Alprostadil—Body temperature increased—Timolol—coronary artery disease	5.45e-05	0.000273	CcSEcCtD
Alprostadil—Dizziness—Losartan—coronary artery disease	5.44e-05	0.000272	CcSEcCtD
Alprostadil—Rash—Furosemide—coronary artery disease	5.37e-05	0.000269	CcSEcCtD
Alprostadil—Dermatitis—Furosemide—coronary artery disease	5.37e-05	0.000269	CcSEcCtD
Alprostadil—Nausea—Captopril—coronary artery disease	5.36e-05	0.000269	CcSEcCtD
Alprostadil—Headache—Furosemide—coronary artery disease	5.34e-05	0.000267	CcSEcCtD
Alprostadil—Feeling abnormal—Lisinopril—coronary artery disease	5.27e-05	0.000264	CcSEcCtD
Alprostadil—Nausea—Perindopril—coronary artery disease	5.21e-05	0.000261	CcSEcCtD
Alprostadil—Rash—Losartan—coronary artery disease	5.19e-05	0.00026	CcSEcCtD
Alprostadil—Dermatitis—Losartan—coronary artery disease	5.18e-05	0.000259	CcSEcCtD
Alprostadil—Headache—Losartan—coronary artery disease	5.15e-05	0.000258	CcSEcCtD
Alprostadil—Nausea—Furosemide—coronary artery disease	5.06e-05	0.000254	CcSEcCtD
Alprostadil—Asthenia—Ramipril—coronary artery disease	5.06e-05	0.000253	CcSEcCtD
Alprostadil—Abdominal pain—Lisinopril—coronary artery disease	5.06e-05	0.000253	CcSEcCtD
Alprostadil—Body temperature increased—Lisinopril—coronary artery disease	5.06e-05	0.000253	CcSEcCtD
Alprostadil—Pruritus—Ramipril—coronary artery disease	4.99e-05	0.00025	CcSEcCtD
Alprostadil—Asthenia—Timolol—coronary artery disease	4.95e-05	0.000248	CcSEcCtD
Alprostadil—Nausea—Losartan—coronary artery disease	4.88e-05	0.000245	CcSEcCtD
Alprostadil—Pruritus—Timolol—coronary artery disease	4.88e-05	0.000244	CcSEcCtD
Alprostadil—Diarrhoea—Ramipril—coronary artery disease	4.82e-05	0.000242	CcSEcCtD
Alprostadil—Diarrhoea—Timolol—coronary artery disease	4.72e-05	0.000236	CcSEcCtD
Alprostadil—Dizziness—Ramipril—coronary artery disease	4.66e-05	0.000234	CcSEcCtD
Alprostadil—Asthenia—Lisinopril—coronary artery disease	4.59e-05	0.00023	CcSEcCtD
Alprostadil—Dizziness—Timolol—coronary artery disease	4.56e-05	0.000228	CcSEcCtD
Alprostadil—Pruritus—Lisinopril—coronary artery disease	4.52e-05	0.000227	CcSEcCtD
Alprostadil—Rash—Ramipril—coronary artery disease	4.45e-05	0.000223	CcSEcCtD
Alprostadil—Dermatitis—Ramipril—coronary artery disease	4.44e-05	0.000222	CcSEcCtD
Alprostadil—Headache—Ramipril—coronary artery disease	4.42e-05	0.000221	CcSEcCtD
Alprostadil—Diarrhoea—Lisinopril—coronary artery disease	4.38e-05	0.000219	CcSEcCtD
Alprostadil—Rash—Timolol—coronary artery disease	4.35e-05	0.000218	CcSEcCtD
Alprostadil—Dermatitis—Timolol—coronary artery disease	4.34e-05	0.000217	CcSEcCtD
Alprostadil—Headache—Timolol—coronary artery disease	4.32e-05	0.000216	CcSEcCtD
Alprostadil—Dizziness—Lisinopril—coronary artery disease	4.23e-05	0.000212	CcSEcCtD
Alprostadil—Nausea—Ramipril—coronary artery disease	4.19e-05	0.00021	CcSEcCtD
Alprostadil—Nausea—Timolol—coronary artery disease	4.09e-05	0.000205	CcSEcCtD
Alprostadil—Rash—Lisinopril—coronary artery disease	4.03e-05	0.000202	CcSEcCtD
Alprostadil—Dermatitis—Lisinopril—coronary artery disease	4.03e-05	0.000202	CcSEcCtD
Alprostadil—Headache—Lisinopril—coronary artery disease	4.01e-05	0.000201	CcSEcCtD
Alprostadil—Nausea—Lisinopril—coronary artery disease	3.8e-05	0.00019	CcSEcCtD
Alprostadil—ABCC5—Metabolism—GGT1—coronary artery disease	1.33e-05	9.92e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AGT—coronary artery disease	1.32e-05	9.9e-05	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.32e-05	9.86e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APOE—coronary artery disease	1.3e-05	9.7e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—LEP—coronary artery disease	1.3e-05	9.7e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF1—coronary artery disease	1.29e-05	9.67e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—LPL—coronary artery disease	1.28e-05	9.6e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ITGAV—coronary artery disease	1.28e-05	9.59e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ITGAV—coronary artery disease	1.28e-05	9.59e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APOA1—coronary artery disease	1.28e-05	9.59e-05	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—TGFB1—coronary artery disease	1.28e-05	9.58e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KNG1—coronary artery disease	1.28e-05	9.56e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KNG1—coronary artery disease	1.28e-05	9.56e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CREB1—coronary artery disease	1.27e-05	9.53e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—POMC—coronary artery disease	1.27e-05	9.53e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—POMC—coronary artery disease	1.27e-05	9.53e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CREB1—coronary artery disease	1.27e-05	9.53e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—IGF1—coronary artery disease	1.27e-05	9.52e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AGTR1—coronary artery disease	1.27e-05	9.5e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AGTR1—coronary artery disease	1.27e-05	9.5e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—KDR—coronary artery disease	1.27e-05	9.5e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK14—coronary artery disease	1.26e-05	9.44e-05	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	1.26e-05	9.42e-05	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—MAPK1—coronary artery disease	1.26e-05	9.39e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL2—coronary artery disease	1.25e-05	9.32e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL2—coronary artery disease	1.25e-05	9.32e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6R—coronary artery disease	1.24e-05	9.3e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6R—coronary artery disease	1.24e-05	9.3e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL10—coronary artery disease	1.24e-05	9.29e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL10—coronary artery disease	1.24e-05	9.29e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PLG—coronary artery disease	1.24e-05	9.26e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PLG—coronary artery disease	1.24e-05	9.26e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ESR1—coronary artery disease	1.24e-05	9.26e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FN1—coronary artery disease	1.22e-05	9.15e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—F2—coronary artery disease	1.22e-05	9.15e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6ST—coronary artery disease	1.22e-05	9.11e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SERPINE1—coronary artery disease	1.21e-05	9.04e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NFKBIA—coronary artery disease	1.21e-05	9.04e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ALB—coronary artery disease	1.21e-05	9.02e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRB2—coronary artery disease	1.21e-05	9.02e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRB2—coronary artery disease	1.21e-05	9.02e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PPP2CA—coronary artery disease	1.2e-05	9.01e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTP1—coronary artery disease	1.19e-05	8.91e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCE—coronary artery disease	1.19e-05	8.9e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCE—coronary artery disease	1.19e-05	8.9e-05	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—JAK2—coronary artery disease	1.19e-05	8.9e-05	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—JAK2—coronary artery disease	1.19e-05	8.9e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SOCS1—coronary artery disease	1.19e-05	8.88e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SOCS1—coronary artery disease	1.19e-05	8.88e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—S100B—coronary artery disease	1.18e-05	8.86e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—S100B—coronary artery disease	1.18e-05	8.86e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PRKCD—coronary artery disease	1.18e-05	8.85e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARGC1A—coronary artery disease	1.18e-05	8.83e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HMOX1—coronary artery disease	1.17e-05	8.79e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SOCS3—coronary artery disease	1.17e-05	8.77e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SOCS3—coronary artery disease	1.17e-05	8.77e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—KIT—coronary artery disease	1.17e-05	8.76e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAT—coronary artery disease	1.16e-05	8.67e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFBR2—coronary artery disease	1.16e-05	8.67e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KITLG—coronary artery disease	1.16e-05	8.67e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFBR2—coronary artery disease	1.16e-05	8.67e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KITLG—coronary artery disease	1.16e-05	8.67e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTHFR—coronary artery disease	1.16e-05	8.64e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS3—coronary artery disease	1.15e-05	8.63e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—STAT5A—coronary artery disease	1.13e-05	8.47e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—STAT5A—coronary artery disease	1.13e-05	8.47e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP3—coronary artery disease	1.13e-05	8.47e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP3—coronary artery disease	1.13e-05	8.47e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOB—coronary artery disease	1.13e-05	8.42e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—GSK3B—coronary artery disease	1.12e-05	8.4e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—JAK2—coronary artery disease	1.12e-05	8.39e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CREB1—coronary artery disease	1.11e-05	8.33e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—POMC—coronary artery disease	1.11e-05	8.33e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HIF1A—coronary artery disease	1.1e-05	8.24e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GSTM1—coronary artery disease	1.09e-05	8.19e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOB—coronary artery disease	1.09e-05	8.19e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOB—coronary artery disease	1.09e-05	8.19e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL2—coronary artery disease	1.09e-05	8.15e-05	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—PIK3CA—coronary artery disease	1.09e-05	8.15e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6R—coronary artery disease	1.09e-05	8.13e-05	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CXCL8—coronary artery disease	1.08e-05	8.12e-05	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CXCL8—coronary artery disease	1.08e-05	8.12e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—JAK2—coronary artery disease	1.08e-05	8.08e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—JAK2—coronary artery disease	1.08e-05	8.08e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—EDN1—coronary artery disease	1.08e-05	8.06e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—EDN1—coronary artery disease	1.08e-05	8.06e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOE—coronary artery disease	1.08e-05	8.05e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—LPL—coronary artery disease	1.07e-05	8.04e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IGF1—coronary artery disease	1.07e-05	8.02e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL5—coronary artery disease	1.07e-05	8e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL5—coronary artery disease	1.07e-05	8e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—MAPK1—coronary artery disease	1.07e-05	7.98e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOA1—coronary artery disease	1.06e-05	7.96e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CSF2—coronary artery disease	1.05e-05	7.88e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CSF2—coronary artery disease	1.05e-05	7.88e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF1—coronary artery disease	1.05e-05	7.88e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF1—coronary artery disease	1.05e-05	7.88e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GPX1—coronary artery disease	1.05e-05	7.84e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LPL—coronary artery disease	1.04e-05	7.82e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LPL—coronary artery disease	1.04e-05	7.82e-05	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—coronary artery disease	1.04e-05	7.81e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MEF2C—coronary artery disease	1.04e-05	7.75e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RPS6KB1—coronary artery disease	1.04e-05	7.75e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RPS6KB1—coronary artery disease	1.04e-05	7.75e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MEF2C—coronary artery disease	1.04e-05	7.75e-05	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.03e-05	7.7e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CD36—coronary artery disease	1.02e-05	7.64e-05	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.02e-05	7.62e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SERPINE1—coronary artery disease	1.02e-05	7.61e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6ST—coronary artery disease	1.01e-05	7.56e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ITGB3—coronary artery disease	1.01e-05	7.55e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ITGB3—coronary artery disease	1.01e-05	7.55e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPP2CA—coronary artery disease	1.01e-05	7.54e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS2—coronary artery disease	1e-05	7.5e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CXCL8—coronary artery disease	9.85e-06	7.37e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CXCL8—coronary artery disease	9.85e-06	7.37e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF2—coronary artery disease	9.85e-06	7.37e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PPP2CA—coronary artery disease	9.8e-06	7.34e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PPP2CA—coronary artery disease	9.8e-06	7.34e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NOS3—coronary artery disease	9.71e-06	7.27e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—KIT—coronary artery disease	9.71e-06	7.26e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—MTHFR—coronary artery disease	9.67e-06	7.24e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCD—coronary artery disease	9.63e-06	7.2e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCD—coronary artery disease	9.63e-06	7.2e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—JAK2—coronary artery disease	9.44e-06	7.06e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR2A—coronary artery disease	9.42e-06	7.05e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR2A—coronary artery disease	9.42e-06	7.05e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—C3—coronary artery disease	9.41e-06	7.04e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—C3—coronary artery disease	9.41e-06	7.04e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—GSK3B—coronary artery disease	9.31e-06	6.97e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—PIK3CA—coronary artery disease	9.25e-06	6.92e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CREB1—coronary artery disease	9.24e-06	6.91e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AGT—coronary artery disease	9.19e-06	6.88e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6R—coronary artery disease	9.01e-06	6.74e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOE—coronary artery disease	9.01e-06	6.74e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HIF1A—coronary artery disease	8.97e-06	6.71e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HIF1A—coronary artery disease	8.97e-06	6.71e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AGT—coronary artery disease	8.94e-06	6.69e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AGT—coronary artery disease	8.94e-06	6.69e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOA1—coronary artery disease	8.9e-06	6.66e-05	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—AKT1—coronary artery disease	8.9e-06	6.66e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—LEP—coronary artery disease	8.76e-06	6.55e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—LEP—coronary artery disease	8.76e-06	6.55e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOE—coronary artery disease	8.76e-06	6.55e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOE—coronary artery disease	8.76e-06	6.55e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOA1—coronary artery disease	8.66e-06	6.48e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOA1—coronary artery disease	8.66e-06	6.48e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CXCL8—coronary artery disease	8.62e-06	6.45e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KDR—coronary artery disease	8.58e-06	6.42e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KDR—coronary artery disease	8.58e-06	6.42e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK14—coronary artery disease	8.52e-06	6.38e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK14—coronary artery disease	8.52e-06	6.38e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SERPINE1—coronary artery disease	8.44e-06	6.31e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ESR1—coronary artery disease	8.36e-06	6.26e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ESR1—coronary artery disease	8.36e-06	6.26e-05	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—AKT1—coronary artery disease	8.32e-06	6.23e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—coronary artery disease	8.31e-06	6.22e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FN1—coronary artery disease	8.26e-06	6.18e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—F2—coronary artery disease	8.26e-06	6.18e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FN1—coronary artery disease	8.26e-06	6.18e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—F2—coronary artery disease	8.26e-06	6.18e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CASP3—coronary artery disease	8.25e-06	6.17e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6ST—coronary artery disease	8.23e-06	6.16e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6ST—coronary artery disease	8.23e-06	6.16e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—IL6—coronary artery disease	8.19e-06	6.13e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF2—coronary artery disease	8.17e-06	6.11e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NFKBIA—coronary artery disease	8.16e-06	6.11e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NFKBIA—coronary artery disease	8.16e-06	6.11e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS3—coronary artery disease	8.06e-06	6.03e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCND1—coronary artery disease	8.03e-06	6.01e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KIT—coronary artery disease	7.9e-06	5.91e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KIT—coronary artery disease	7.9e-06	5.91e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PPARG—coronary artery disease	7.85e-06	5.87e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—JAK2—coronary artery disease	7.83e-06	5.86e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—coronary artery disease	7.79e-06	5.83e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—POMC—coronary artery disease	7.74e-06	5.79e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—TGFB1—coronary artery disease	7.63e-06	5.71e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GSK3B—coronary artery disease	7.59e-06	5.68e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GSK3B—coronary artery disease	7.59e-06	5.68e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—AKT1—coronary artery disease	7.56e-06	5.66e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—POMC—coronary artery disease	7.52e-06	5.63e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—POMC—coronary artery disease	7.52e-06	5.63e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CREB1—coronary artery disease	7.52e-06	5.63e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CREB1—coronary artery disease	7.52e-06	5.63e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—MAPK1—coronary artery disease	7.48e-06	5.6e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—coronary artery disease	7.37e-06	5.51e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL2—coronary artery disease	7.36e-06	5.51e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL2—coronary artery disease	7.36e-06	5.51e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6R—coronary artery disease	7.34e-06	5.49e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6R—coronary artery disease	7.34e-06	5.49e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IGF1—coronary artery disease	7.24e-06	5.42e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IGF1—coronary artery disease	7.24e-06	5.42e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—MAPK1—coronary artery disease	7.2e-06	5.39e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—MAPK1—coronary artery disease	7.2e-06	5.39e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—coronary artery disease	7.05e-06	5.28e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—coronary artery disease	7e-06	5.24e-05	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PIK3CA—coronary artery disease	6.88e-06	5.15e-05	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PIK3CA—coronary artery disease	6.88e-06	5.15e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SERPINE1—coronary artery disease	6.87e-06	5.14e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SERPINE1—coronary artery disease	6.87e-06	5.14e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—NOS3—coronary artery disease	6.75e-06	5.05e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF2—coronary artery disease	6.65e-06	4.98e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF2—coronary artery disease	6.65e-06	4.98e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NOS3—coronary artery disease	6.56e-06	4.91e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NOS3—coronary artery disease	6.56e-06	4.91e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PIK3CA—coronary artery disease	6.49e-06	4.86e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TGFB1—coronary artery disease	6.42e-06	4.81e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JAK2—coronary artery disease	6.38e-06	4.77e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JAK2—coronary artery disease	6.38e-06	4.77e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MAPK1—coronary artery disease	6.3e-06	4.71e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PIK3CA—coronary artery disease	6.25e-06	4.68e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PIK3CA—coronary artery disease	6.25e-06	4.68e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—coronary artery disease	6.17e-06	4.62e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL8—coronary artery disease	5.82e-06	4.36e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL8—coronary artery disease	5.82e-06	4.36e-05	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AKT1—coronary artery disease	5.62e-06	4.21e-05	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AKT1—coronary artery disease	5.62e-06	4.21e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CASP3—coronary artery disease	5.57e-06	4.17e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CASP3—coronary artery disease	5.57e-06	4.17e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6—coronary artery disease	5.53e-06	4.14e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6—coronary artery disease	5.53e-06	4.14e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PIK3CA—coronary artery disease	5.47e-06	4.09e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCND1—coronary artery disease	5.42e-06	4.06e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCND1—coronary artery disease	5.42e-06	4.06e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TGFB1—coronary artery disease	5.33e-06	3.99e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—AKT1—coronary artery disease	5.3e-06	3.97e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—coronary artery disease	5.26e-06	3.94e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—coronary artery disease	5.26e-06	3.94e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MAPK1—coronary artery disease	5.22e-06	3.91e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AKT1—coronary artery disease	5.11e-06	3.82e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AKT1—coronary artery disease	5.11e-06	3.82e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6—coronary artery disease	4.84e-06	3.62e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—coronary artery disease	4.73e-06	3.54e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—coronary artery disease	4.73e-06	3.54e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PIK3CA—coronary artery disease	4.53e-06	3.39e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT1—coronary artery disease	4.47e-06	3.34e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TGFB1—coronary artery disease	4.34e-06	3.25e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TGFB1—coronary artery disease	4.34e-06	3.25e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MAPK1—coronary artery disease	4.25e-06	3.18e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MAPK1—coronary artery disease	4.25e-06	3.18e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6—coronary artery disease	4.01e-06	3e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PIK3CA—coronary artery disease	3.8e-06	2.84e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT1—coronary artery disease	3.7e-06	2.77e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PIK3CA—coronary artery disease	3.69e-06	2.76e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PIK3CA—coronary artery disease	3.69e-06	2.76e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6—coronary artery disease	3.27e-06	2.45e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6—coronary artery disease	3.27e-06	2.45e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKT1—coronary artery disease	3.1e-06	2.32e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT1—coronary artery disease	3.02e-06	2.26e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT1—coronary artery disease	3.02e-06	2.26e-05	CbGpPWpGaD
